Key facts
- This page summarizes Andrew Emerson's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
- 15 reported transactions and 9 derivative rows are listed below.
- Accepted by SEC: 17 Feb 2026, 19:30.
Andrew Emerson - 12 Feb 2026 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)
- Reporting relationship
- EVP, CFO and Treasurer
- Issuer ticker
- IDXX
- Reported as of
- 12 Feb 2026
- Net transaction value
- -$77,410
- SEC form
- 4
- Accepted by SEC
- 17 Feb 2026, 19:30:10 UTC
- Prior SEC filing
- 11 Aug 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lily J. Lu, Attorney-in-Fact for Andrew Emerson
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Andrew Emerson filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 17 Feb 2026.
Change
- Previous filing in this sequence was filed on 11 Aug 2025.
- Current net transaction value: -$77,410.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002058587
Primary reporting owner
Emerson Andrew
- Relationship
- EVP, CFO and Treasurer
- Address
- ONE IDEXX DRIVE, WESTBROOK
- Signature
- /s/ Lily J. Lu, Attorney-in-Fact for Andrew Emerson
- Signature date
- 17 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +61
- Change %
- +1.6%
- Price
- $0.000000
- Shares after
- 3,950
- Date
- 14 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +94
- Change %
- +2.4%
- Price
- $0.000000
- Shares after
- 4,044
- Date
- 14 Feb 2026
- Ownership
- Direct
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +42
- Change %
- +1%
- Price
- $0.000000
- Shares after
- 4,086
- Date
- 14 Feb 2026
- Ownership
- Direct
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +194
- Change %
- +4.7%
- Price
- $0.000000
- Shares after
- 4,280
- Date
- 14 Feb 2026
- Ownership
- Direct
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +65
- Change %
- +1.5%
- Price
- $0.000000
- Shares after
- 4,345
- Date
- 14 Feb 2026
- Ownership
- Direct
- Footnotes
- F2
IDXX
transaction
Common Stock
Tax liability
- Transaction value
- $77,410
- Shares
- -123
- Change %
- -2.8%
- Price
- $629.35
- Shares after
- 4,222
- Date
- 14 Feb 2026
- Ownership
- Direct
- Footnotes
- F3, F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IDXX
transaction
Derivative
Non-Qualified Stock Option (right-to-buy)
Award
- Transaction value
- $0
- Shares
- +4,270
- Change %
- Price
- $0.000000
- Shares after
- 4,270
- Date
- 12 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,270
- Exercise price
- $617.20
- Footnotes
- F5
IDXX
transaction
Derivative
Incentive Stock Option (right-to-buy)
Award
- Transaction value
- $0
- Shares
- +162
- Change %
- Price
- $0.000000
- Shares after
- 162
- Date
- 12 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 162
- Exercise price
- $617.20
- Footnotes
- F6
IDXX
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +729
- Change %
- Price
- $0.000000
- Shares after
- 729
- Date
- 12 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 729
- Exercise price
- Footnotes
- F7
IDXX
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +284
- Change %
- Price
- $0.000000
- Shares after
- 284
- Date
- 12 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 284
- Exercise price
- Footnotes
- F8
IDXX
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -65
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 193
- Date
- 12 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 65
- Exercise price
- Footnotes
- F9
IDXX
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -61
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 14 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 61
- Exercise price
- Footnotes
- F10
IDXX
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -94
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 93
- Date
- 14 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 94
- Exercise price
- Footnotes
- F11
IDXX
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -42
- Change %
- -34%
- Price
- $0.000000
- Shares after
- 83
- Date
- 14 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 42
- Exercise price
- Footnotes
- F12
IDXX
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -194
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 581
- Date
- 14 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 194
- Exercise price
- Footnotes
- F13
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 13 footnotes
Footnote F1
Includes a total of 18.666 shares purchased under the Issuer Employee Stock Purchase Plan on September 30, 2025 and December 31, 2025.
Footnote F2
Represents Restricted Stock Units ('RSU') that were granted on February 14, 2025, were deferred in accordance with the Issuer's Deferred Compensation Plan and have vested. Upon vesting, these RSUs were recorded in an account under such Plan and represents a contingent right to receive one share of Issuer common stock that is payable as soon as practicable after the reporting person's separation of service with the Issuer or a date specified by the reporting person.
Footnote F3
Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026.
Footnote F4
Includes 65 vested but deferred RSUs.
Footnote F5
Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027.
Footnote F6
Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030.
Footnote F7
Each RSU represents a contingent right to receive one share of Issuer common stock that vests in four annual installments, beginning February 14, 2027.
Footnote F8
Grant of RSUs that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in four annual installments, beginning February 14, 2027.
Footnote F9
Represents RSUs that were granted on February 14, 2025 and deferred in accordance with the Issuer's Deferred Compensation Plan and represents a contingent right to receive one share of Issuer common stock vesting in four annual installments, beginning February 14, 2026. Upon vesting, each such RSU will be recorded in an account under such Plan.
Footnote F10
Represents RSUs that were granted on February 14, 2025 and deferred in accordance with the Issuer's Deferred Compensation Plan and represents a contingent right to receive one share of Issuer common stock vesting in four annual installments, beginning February 14, 2026. Upon vesting, each such RSU will be recorded in an account under such Plan.
Footnote F11
Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2024.
Footnote F12
Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025.
Footnote F13
Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2026.